tiprankstipranks
Bone Biologics Corp. (BBLG)
NASDAQ:BBLG
US Market
Holding BBLG?
Track your performance easily

Bone Biologics (BBLG) Financial Statements

62 Followers

Bone Biologics Financial Overview

Bone Biologics's market cap is currently ―. The company's EPS TTM is $-5.418; its P/E ratio is -0.19; Bone Biologics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -941.00K$ -783.73K$ 940.85K$ -1.16M$ -2.08M
EBITDA$ -941.00K$ -783.73K$ 940.85K$ -1.16M$ -2.08M
Net Income Common Stockholders$ -4.15M$ -783.73K$ -900.00K$ -1.55M$ -1.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.60M$ 2.30M$ 3.20M$ 3.00M$ 4.50M
Total Assets$ 4.07M$ 3.19M$ 3.84M$ 3.74M$ 4.98M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.60M$ -2.30M$ -3.20M$ -3.00M$ -4.50M
Total Liabilities$ 273.40K$ 284.51K$ 164.63K$ 831.40K$ 1.18M
Stockholders Equity$ 3.79M$ 2.91M$ 3.67M$ 2.91M$ 3.79M
Cash Flow-
Free Cash Flow$ -600.00K$ -900.00K$ -1.30M$ -2.02M$ -2.56M
Operating Cash Flow$ -600.00K$ -900.00K$ -1.30M$ -2.02M$ -2.56M
Investing Cash Flow-----
Financing Cash Flow$ 1.81M$ 299.00$ 1.50M$ 592.00K-
Currency in USD

Bone Biologics Earnings and Revenue History

Bone Biologics Debt to Assets

Bone Biologics Cash Flow

Bone Biologics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis